BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27470709)

  • 1. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
    Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
    Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
    Malkan UY; Ozcebe OI
    Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
    Cline A; Jajosky R; Shikle J; Bollag R
    J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
    Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
    J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
    Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
    Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
    Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
    Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
    J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
    Song J; Shang B; Pei Y; Shi M; Niu X; Dou L; Drokow EK; Xu F; Bai Y; Sun K
    Leuk Res; 2021 Oct; 109():106638. PubMed ID: 34116372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.